Total submissions: 13
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000152665 | SCV000169814 | benign | not specified | 2013-03-20 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Laboratory for Molecular Medicine, |
RCV000152665 | SCV000202023 | benign | not specified | 2012-04-30 | criteria provided, single submitter | clinical testing | Arg161Gln in Exon 05 of WFS1: This variant is not expected to have clinical sign ificance because it has been identified in 0.7% (28/3738) of African American ch romosomes from a broad population by the NHLBI Exome Sequencing Project (http:// evs.gs.washington.edu/EVS; dbSNP rs115346085). |
Eurofins Ntd Llc |
RCV000152665 | SCV000231088 | likely benign | not specified | 2014-08-04 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000756925 | SCV000884912 | benign | not provided | 2018-02-02 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000756925 | SCV001013404 | benign | not provided | 2025-02-01 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001154623 | SCV001316000 | benign | Autosomal dominant nonsyndromic hearing loss 6 | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Illumina Laboratory Services, |
RCV001154624 | SCV001316001 | likely benign | WFS1-Related Spectrum Disorders | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. |
Fulgent Genetics, |
RCV002483249 | SCV002795822 | likely benign | Cataract 41; Wolfram syndrome 1; Autosomal dominant nonsyndromic hearing loss 6; Type 2 diabetes mellitus; Wolfram-like syndrome | 2022-05-12 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000756925 | SCV005257156 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Genome |
RCV000709886 | SCV000840227 | not provided | Wolfram syndrome 1; Autosomal dominant nonsyndromic hearing loss 6; Wolfram-like syndrome | no assertion provided | phenotyping only | GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. | |
Clinical Genetics, |
RCV000756925 | SCV001921760 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000756925 | SCV001972294 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000756925 | SCV002036012 | likely benign | not provided | no assertion criteria provided | clinical testing |